Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Latent IgA deposition from donor kidneys does not affect transplant prognosis, irrespective of mesangial expansion.

Sofue T, Inui M, Hara T, Moritoki M, Nishioka S, Nishijima Y, Moriwaki K, Hayashida Y, Ueda N, Kushida Y, Haba R, Nishiyama A, Kakehi Y, Kohno M.

Clin Transplant. 2013 Nov-Dec;27 Suppl 26:14-21. doi: 10.1111/ctr.12158.

PMID:
24299231
2.

Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.

Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y.

Clin Transplant. 2005;19 Suppl 14:41-8.

PMID:
15955168
3.

The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.

Ji S, Liu M, Chen J, Yin L, Sha G, Chen H, Liu Z, Li L.

Clin Transplant. 2004 Oct;18(5):536-40.

PMID:
15344956
4.

Association between post-transplantation immunoglobulin A deposition and reduced allograft function.

Sofue T, Inui M, Hara T, Moritoki M, Nishijima Y, Kushida Y, Nishiyama A, Kakehi Y, Kohno M.

Transplant Proc. 2015 Mar;47(2):332-6. doi: 10.1016/j.transproceed.2015.01.011.

PMID:
25769568
5.

Long-term course of post-transplant mesangial IgA deposition: clinicopathologic study of nine cases.

Hara S, Yamaguchi Y, Hara S, Tanimoto A, Seki K, Matsushita H, Tomikawa S, Kuzuhara K.

Clin Transplant. 2005;19 Suppl 14:32-40.

PMID:
15955167
6.

Incidence of latent mesangial IgA deposition in renal allograft donors in Japan.

Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y.

Kidney Int. 2003 Jun;63(6):2286-94.

7.

Latent mesangial immunoglobulin A deposition in long-term functioning kidney does not correlate with disease progression and may exhibit fluctuating patterns.

Hara S, Ichimaru N, Kyo M, Yamaguchi Y, Kojima Y, Takahara S, Itoh T.

Transplant Proc. 2014 Jan-Feb;46(1):124-9. doi: 10.1016/j.transproceed.2013.07.072.

PMID:
24507037
8.

Pre-existing arteriosclerotic intimal thickening in living-donor kidneys reflects allograft function.

Sofue T, Inui M, Kiyomoto H, Moritoki M, Nishioka S, Nishijima Y, Moriwaki K, Hara T, Kushida Y, Haba R, Yoda T, Hirao T, Kakehi Y, Nishiyama A, Kohno M.

Am J Nephrol. 2012;36(2):127-35. doi: 10.1159/000340035. Epub 2012 Jul 13.

PMID:
22797609
9.

Recurrent mesangial IgA nephritis following renal transplantation.

Odum J, Peh CA, Clarkson AR, Bannister KM, Seymour AE, Gillis D, Thomas AC, Mathew TH, Woodroffe AJ.

Nephrol Dial Transplant. 1994;9(3):309-12.

PMID:
8052439
10.

Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.

Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, Li LS.

Ren Fail. 2008;30(6):611-6. doi: 10.1080/08860220802134516.

PMID:
18661411
11.

Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.

Kennoki T, Ishida H, Yamaguchi Y, Tanabe K.

Transplantation. 2009 Oct 15;88(7):935-41. doi: 10.1097/TP.0b013e3181b75374.

PMID:
19935466
12.

Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy.

Nieuwhof C, Kruytzer M, Frederiks P, van Breda Vriesman PJ.

Am J Kidney Dis. 1998 Jun;31(6):962-70.

PMID:
9631840
13.

Favorable outcome of renal transplantation in patients with IgA nephropathy.

Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF.

Clin Nephrol. 2001 Oct;56(4):279-88.

PMID:
11680657
14.

Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.

Espinosa M, Ortega R, Gómez-Carrasco JM, López-Rubio F, López-Andreu M, López-Oliva MO, Aljama P.

Nephrol Dial Transplant. 2009 Mar;24(3):886-91. doi: 10.1093/ndt/gfn563. Epub 2008 Oct 8.

PMID:
18842673
15.

Recurrent IgA nephropathy in renal transplant allografts.

Wang AY, Lai FM, Yu AW, Lam PK, Chow KM, Choi PC, Lui SF, Li PK.

Am J Kidney Dis. 2001 Sep;38(3):588-96.

PMID:
11532693
16.

Clinical risk factors for recurrence of IgA nephropathy.

Freese P, Svalander C, Nordén G, Nyberg G.

Clin Transplant. 1999 Aug;13(4):313-7.

PMID:
10485372
17.

IgA nephropathy as a donor-transmitted disease in renal transplant recipients.

Koselj M, Rott T, Vizjak A, Kveder R.

Transplant Proc. 1991 Oct;23(5):2643-6. No abstract available.

PMID:
1926514
18.

Beneficial effects of tonsillectomy for mesangial immunoglobulin A (IgA) deposition and clinical outcome in five kidney transplant patients with recurrent IgA nephropathy: case report.

Wang Y, Ichimaru N, Kyo M, Kakuta Y, Okumi M, Kaimori JY, Nonomura N, Fan Y, Takahara S.

Transplant Proc. 2014;46(2):607-9. doi: 10.1016/j.transproceed.2013.11.066.

PMID:
24656024
19.

Molecular basis of IgA nephropathy.

Lai AS, Lai KN.

Curr Mol Med. 2005 Aug;5(5):475-87. Review.

PMID:
16101476
20.

IgA nephropathy recurs early in the graft when assessed by protocol biopsy.

Ortiz F, Gelpi R, Koskinen P, Manonelles A, Räisänen-Sokolowski A, Carrera M, Honkanen E, Grinyó JM, Cruzado JM.

Nephrol Dial Transplant. 2012 Jun;27(6):2553-8. doi: 10.1093/ndt/gfr664. Epub 2011 Dec 13.

PMID:
22167589

Supplemental Content

Support Center